Systematic review: Regression of lymphoproliferative disorders after treatment for hepatitis C infection

Alimentary Pharmacology and Therapeutics

Volumn 21, Issue 6, 2005, Pages 653-662

  Gisbert, J P ^a   Garcia Buey L ^a   Pajares, J M ^a   Moreno Otero, R ^a  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; IMMUNOGLOBULIN HEAVY CHAIN; PROTEIN BCL 2; RIBAVIRIN; VIRUS RNA;

B CELL LYMPHOMA; BIBLIOGRAPHIC DATABASE; CINAHL; CLINICAL TRIAL; COCHRANE LIBRARY; CRYOGLOBULINEMIA; EMBASE; ERADICATION THERAPY; HEPATITIS C; HUMAN; LYMPHOCYTE PROLIFERATION; LYMPHOPROLIFERATIVE DISEASE; MANTLE CELL LYMPHOMA; MEDLINE; META ANALYSIS; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; REMISSION; REVIEW; SIDE EFFECT; SYSTEMATIC REVIEW;

ANTIVIRAL AGENTS; GENE ORDER; GENES, BCL-2; HEPATITIS C; HUMANS; INTERFERON-ALPHA; LYMPHOPROLIFERATIVE DISORDERS; REMISSION INDUCTION; RIBAVIRIN;

EID: 16344376229     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2005.02395.x     Document Type: Review

References (67)

1. Alter MJ, Kruszon-Moran D, Nainan OV, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999; 341: 556-62.
2. Wong JB, McQuillan GM, McHutchison JG, Poynard T. Estimating future hepatitis C morbidity, mortality, and costs in the united States. Am J Public Health 2000; 90: 1562-9.
3. Gumber SC, Chopra S. Hepatitis C: a multifaceted disease. Review of extrahepatic manifestations. Ann Intern Med 1995; 123: 615-20.
4. Pena LR, Nand S, De Maria N, Van Thiel DH. Hepatitis C virus infection and lymphoproliferative disorders. Dig Dis Sci 2000; 45: 1854-60.
5. Ferri C, La Civita L, Zignego AL, Pasero G. Viruses and cancers: possible role of hepatitis C virus. Eur J Clin Invest 1997; 27: 711-8.
6. Silvestri F, Baccarani M. Hepatitis C virus-related lymphomas. Br J Haematol 1997; 99: 475-80.
7. Gasparotto D, De Re V, Boiocchi M. Hepatitis C virus. B-cell proliferation and lymphomas. Leuk Lymphoma 2002; 43: 747-51.
8. Gisbert JP, Garcia-Buey L, Pajares JM, Moreno-Otero R. Prevalence of hepatitis C virus infection in B-cell non-Hodgkin's lymphoma: systematic review and meta-analysis. Gastroenterology 2003; 125: 1723-32.
9. Zuckerman E, Zuckerman T. Hepatitis C and B-cell lymphoma: the hemato-hepatologist linkage. Blood Rev 2002; 16: 119-25.
10. Della Rossa A, Tavoni A, Baldini C, Bombardieri S. Treatment of chronic hepatitis C infection with cryoglobulinemia. Curr Opin Rheumatol 2002; 14: 231-7.
11. Rasul I, Shepherd FA, Kamel-Reid S, Krajden M, Pantalony D, Heathcote EJ. Detection of occult low-grade B-cell non-Hodgkin's lymphoma in patients with chronic hepatitis C infection and mixed cryoglobulinemia. Hepatology 1999; 29: 543-7.
12. Amiel A, Kitay-Cohen Y, Fejgin MD, Lishner M. Replication status as a marker for predisposition for lymphoma in patients with chronic hepatitis C with and without cryoglobulinemia. Exp Hematol 2000; 28: 156-60.
13. Mazzaro C, Carniello GS, Colle R, et al. Interferon therapy in HCV-positive mixed cryoglobulinaemia: viral and host factors contributing to efficacy of the therapy. Ital J Gastroenterol Hepatol 1997; 29: 343-50.
14. Gorevic PD, Frangione B. Mixed cryoglobulinemia cross-reactive idiotypes: implications for the relationship of MC to rheumatic and lymphoproliferative diseases. Semin Hematol 1991; 28: 79-94.
15. Monteverde A, Ballare M, Bertoncelli MC, et al. Lymphoproliferation in type II mixed cryoglobulinemia. Clin Exp Rheumatol 1995; 13 (Suppl. 13): S141-7.
16. Ivanovski M, Silvestri F, Pozzato G, et al. Somatic hypermutation, clonal diversity, and preferential expression of the VH 51p1/VL kv325 immunoglobulin gene combination in hepatitis C virus-associated immunocytomas. Blood 1998; 91: 2433-42.
17. Silvestri F, Barillari G, Fanin R, et al. Impact of hepatitis C virus infection on clinical features, quality of life and survival of patients with lymphoplasmacytoid lymphoma/immunocytoma. Ann Oncol 1998; 9: 499-504.
18. Zignego AL, Ferri C, Giannini C, et al. Hepatitis C virus genotype analysis in patients with type II mixed cryoglobulinemia. Ann Intern Med 1996; 124: 31-4.
19. Dammacco F, Sansonno D, Piccoli C, Racanelli V, D'Amore FP, Lauletta G. The lymphoid system in hepatitis C virus infection: autoimmunity, mixed cryoglobulinemia, and overt B-cell malignancy. Semin Liver Dis 2000; 20: 143-57.
20. Knox TA, Hillyer CD, Kaplan MM, Berkman EM. Mixed cryoglobulinemia responsive to interferon-alpha. Am J Med 1991; 91: 554-5.
21. Durand JM, Kaplanski G, Lefevre P, et al. Effect of interferon-alpha 2b on cryoglobulinemia related to hepatitis C virus infection. J Infect Dis 1992; 165: 778-9.
22. Ferri C, Marzo E, Longombardo G, et al. Interferon-alpha in mixed cryoglobulinemia patients: a randomized, crossover-controlled trial. Blood 1993; 81: 1132-6.
23. Lunel F, Musset L, Cacoub P, et al. Cryoglobulinemia in chronic liver diseases: role of hepatitis C virus and liver damage. Gastroenterology 1994; 106: 1291-300.
24. Mazzaro C, Pozzato G, Moretti M, et al. Long-term effects of alpha-interferon therapy for type II mixed cryoglobulinemia. Haematologica 1994; 79: 342-9.
25. Misiani R, Bellavita P, Fenili D, et al. Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus. N Engl J Med 1994; 330: 751-6.
26. Calleja JL, Albillos A, Moreno-Otero R, et al. Sustained response to interferon-alpha or to interferon-alpha plus ribavirin in hepatitis C virus-associated symptomatic mixed cryoglobulinaemia. Aliment Pharmacol Ther 1999; 13: 1179-86.
27. Kryczka W, Kisiel E. Hematologic syndromes in hepatitis C virus infection. Przegl Lek 2000; 57: 672-5.
28. Mazzaro C, Franzin F, Tulissi P, et al. Regression of monoclonal B-cell expansion in patients affected by mixed cryoglobulinemia responsive to alpha-interferon therapy. Cancer 1996; 77: 2604-13.
29. Silvestri F, Barillari G, Fanin R, et al. The genotype of the hepatitis C virus in patients with HCV-related B cell non-Hodgkin's lymphoma. Leukemia 1997; 11: 2157-61.
30. Zuckerman E, Zuckerman T, Sahar D, et al. The effect of antiviral therapy on t(14;18) translocation and immunoglobulin gene rearrangement in patients with chronic hepatitis C virus infection. Blood 2001; 97: 1555-9.
31. Mazzaro C, Little D'A, Pozzato G, et al. Regression of splenic lymphoma after treatment of hepatitis C virus infection. N Engl J Med 2002; 347: 2168-70; author reply 2168-70.
32. Agnello V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 1992; 327: 1490-5.
33. Dammacco F, Sansonno D, Han JH, et al. Natural interferon-alpha versus its combination with 6-methyl-prednisolone in the therapy of type II mixed cryoglobulinemia: a long-term, randomized, controlled study. Blood 1994; 84: 3336-43.
34. Zignego AL, Giannelll F, Marrocchi ME, et al. T(14;18) translocation in chronic hepatitis C virus infection. Hepatology 2000; 31: 474-9.
35. Zignego AL, Ferri C, Giannelli F, et al. Prevalence of bcl-2 rearrangement in patients with hepatitis C virus-related mixed cryoglobulinemia with or without B-cell lymphomas. Ann Intern Med 2002; 137: 571-80.
36. Kitay-Cohen Y, Amiel A, Hilzenrat N, et al. Bcl-2 rearrangement in patients with chronic hepatitis C associated with essential mixed cryoglobulinemia type II. Blood 2000; 96: 2910-2.
37. Casato M, Mecucci C, Agnello V, et al. Regression of lymphoproliferative disorder after treatment for hepatitis C virus infection in a patient with partial trisomy 3, Bcl-2 overexpression, and type II cryoglobulinemia. Blood 2002; 99: 2259-61.
38. Mangia A, Clemente R, Musto P, et al. Hepatitis C virus infection and monoclonal gammopathies not associated with cryoglobulinemia. Leukemia 1996; 10: 1209-13.
39. Luppi M, Grazia Ferrari M, Bonaccorsi G, et al. Hepatitis C virus infection in subsets of neoplastic lymphoproliferations not associated with cryoglobulinemia. Leukemia 1996; 10: 351-5.
40. Giannelli F, Moscarella S, Giannini C, et al. Effect of antiviral treatment in patients with chronic HCV infection and t(14;18) translocation. Blood 2003; 102: 1196-201.
41. Schott P, Pott C, Ramadori G, Hartmann H. Hepatitis C virus infection-associated non-cryoglobulinaemic monoclonal IgMkappa gammopathy responsive to interferon-alpha treatment. J Hepatol 1998; 29: 310-5.
42. Arcaini L, Paulli M, Boveri E, et al. Splenic and nodal marginal zone lymphomas are indolent disorders at high hepatitis C virus seroprevalence with distinct presenting features but similar morphologic and phenotypic profiles. Cancer 2004; 100: 107-15.
43. Bauduer F. MALT non-Hodgkin's lymphoma associated with hepatitis C virus infection treated by interferon alpha. Am J Hematol 1996; 53: 209.
44. Caramaschi P, Biasi D, Carletto A, et al. MALT lymphomas of the salivary glands. Review of the literature apropos of a case in a patient with hepatitis C virus infection. Recenti Prog Med 1999; 90: 585-91.
45. Emens LA, Sulkowski MS. Regression of splenic lymphoma after treatment of hepatitis C virus infection. N Engl J Med 2002; 347: 2168-70; author reply 2168-70.
46. Gattoni A, Cecere A, Romano C, Di Martino P, Caiazzo R, Rippa A. Case report of a monoclonal gammopathy in a patient with chronic hepatitis: effects of beta-IFN treatment. Panminerva Med 1996; 38: 175-8.
47. Hashem T, Waked I, El-Masey M. Non-Hodgkin lymphoma (NHL) and hepatitis C in Egypt: frequency of infection, clinical characteristics, and response to therapy in a randomized controlled trial. Hepatology 1997; 26: 1571.
48. Hermine O, Lefrere F, Bronowicki JP, et al. Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. N Engl J Med 2002; 347: 89-94.
49. Lamprecht P, Lerin-Lozano C, Merz H, et al. Rituximab induces remission in refractory HCV associated cryoglobulinaemic vasculitis. Ann Rheum Dis 2003; 62: 1230-3.
50. Levine AM, Shimodaira S, Lai MM. Treatment of HCV-related mantle-cell lymphoma with ribavirin and pegylated interferon alfa. N Engl J Med 2003; 349: 2078-9.
51. Moccia F, Tognoni E, Boccaccio P. The relationship between splenic marginal zone B-cell lymphoma and chronic liver disease associated with hepatitis C virus infection. Ann Ital Med Int 1999; 14: 288-93.
52. Patriarca F, Silvestri F, Fanin R, Zaja F, Sperotto A, Baccarani M. Long-lasting complete remission of hepatitis C virus (HCV) infection and HCV-associated immunocytoma with alpha-interferon treatment. Br J Haematol 2001; 112: 370-2.
53. Stolte M, Bayerdorffer E, Morgner A, et al. Helicobacter and gastric MALT lymphoma. Gut 2002; 50 (Suppl. 3): III19-24.
54. Tursi A, Brandimarte G, Torello M. Disappearance of gastric mucosa-associated lymphoid tissue in hepatitis C virus-positive patients after anti-hepatitis C virus therapy. J Clin Gastroenterol 2004; 38: 360-3.
55. Negro F. Hepatitis C virus and lymphomagenesis: another piece of evidence. Hepatology 2002; 36: 1539-42.
56. Roggero E, Zucca E, Mainetti C, et al. Eradication of Borrelia burgdorferi infection in primary marginal zone B-cell lymphoma of the skin. Hum Pathol 2000; 31: 263-8.
57. Rooney CM, Smith CA, Ng CY, et al. Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients. Blood 1998; 92: 1549-55.
58. Pagano JS. Viruses and lymphomas. N Engl J Med 2002; 347: 78-9.
59. Zuckerman E, Zuckerman T, Levine AM, et al. Hepatitis C virus infection in patients with B-cell non-Hodgkin lymphoma. Ann Intern Med 1997; 127: 423-8.
60. Vallisa D, Berte R, Rocca A, et al. Association between hepatitis C virus and non-Hodgkin's lymphoma, and effects of viral infection on histologic subtype and clinical course. Am J Med 1999; 106: 556-60.
61. Zuckerman E, Zuckerman T, Douer D, Qian D, Levine AM. Liver dysfunction in patients infected with hepatitis C virus undergoing chemotherapy for hematologic malignancies. Cancer 1998; 83: 1224-30.
62. Izumi T, Sasaki R, Miura Y, Okamoto H. B cell malignancy and hepatitis C virus infection. Leuk Res 1996; 20: 445.
63. Sanchez Ruiz AC, Yebra Bango M, Portero F, Provencio Pulla M, Miralles Flores C, Espana Saz P. Prevalence of hepatitis C virus infection in patients with non-Hodgkin's lymphoma. Med Clin (Barc) 2001; 116: 333-4.
64. Mizorogi F, Hiramoto J, Nozato A, et al. Hepatitis C virus infection in patients with B-cell non-Hodgkin's lymphoma. Intern Med 2000; 39: 112-7.
65. Zuckerman E, Zuckerman T, Sahar D, et al. Bcl-2 and immunoglobulin gene rearrangement in patients with hepatitis C virus infection. Br J Haematol 2001; 112: 364-9.
66. Mazzaro C, Zagonel V, Monfardini S, et al. Hepatitis C virus and non-Hodgkin's lymphomas. Br J Haematol 1996; 94: 544-50.
67. Strasser SI, McDonald GB. Hepatitis viruses and hematopoietic cell transplantation: a guide to patient and donor management. Blood 1999; 93: 1127-36.